Dr. Melissa Ann Will, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 800 Wilson Ave Rm 330, Menomonie, WI 54751 Phone: 715-256-7166 |
Mrs. Amanda Marie Thomas Evans, PHD LPC NCC Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 808 Main St E, Menomonie, WI 54751 Phone: 715-231-2702 Fax: 715-232-5987 |
Tonya Klem, ED.S Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 800 Wilson Ave, Menomonie, WI 54751 Phone: 715-256-7166 |
News Archive
Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.
It may have been the most influential magazine article of the past decade. In June of 2009, the doctor and writer Atul Gawande published a piece in The New Yorker called "The Cost Conundrum," which examined why the small border city of McAllen, Tex., was the most expensive place for health care in the United States. ... Five years later, the situation has changed. Where McAllen once illustrated the problem of American health care, the city is now showing us how the problem can be solved, largely because of the Affordable Care Act that Mr. Obama signed into law in 2010 (Bob Kocher and Farzad Mostashari, 9/23).
Cold winds, icy rain and, in some places, snow—Old Man Winter is here. With the snowball fights, snow forts and snowy hills come some serious dangers. In addition to ducking from flying snow balls and avoiding out-of-control skiers, parents need to be on the lookout for dangerously low body temperatures and frostbite related to cold weather exposure.
In a presentation at the Conference on Lasers and Electro-Optics (CLEO), researchers from Cedars-Sinai Medical Center's Biophotonics Research and Technology Development Laboratory described recent progress on a device that stimulates, collects and measures light emissions from body tissues to diagnose critical atherosclerotic plaques (vulnerable plaques) and aggressive brain tumors.
A compound developed to treat neuropathic pain has shown potential as an innovative treatment for Alzheimer's disease, according to a study by researchers at Cleveland Clinic's Lerner Research Institute and Anesthesiology Institute.
› Verified 5 days ago